Ashby, Frederick
Park, Haesuk
Svensson, Mikael
Heldermon, Coy D.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS102624, R01NS102624)
Article History
Received: 6 August 2023
Accepted: 14 September 2025
First Online: 10 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: Dr Coy D Heldermon: Patent pending for an AAV gene therapy vector for Sanfilippo Type B.
: CDC NVSS for past years. .IHME 2017–2100 projection for future years. .
: [ ].
: [ , ].
: .
: .
: Disability Weights [ ].